Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.
 

Newsweek ranked the 50 best heart hospitals in the world

Deaths from CVD are on the rise, cardiologists warn—high blood pressure, obesity remain 2 primary culprits

Cardiovascular disease remains one of the leading causes of mortality in the world, responsible for nearly 20 million deaths in 2022 alone. 

artificial intelligence money finance acquisition

Medtronic backs out of $738M acquisition due to ‘multiple breaches’

Medtronic confirmed its decision in a statement, but did not provide any specific details. The deal was originally announced in May.

Thumbnail

Statin therapy benefits high-risk patients with no prior history of CVD

Two separate studies examined the controversial topic of prescribing statins to high-risk elderly patients who do not already have high cholesterol or cardiovascular disease.

doctor fruits vegetables vegetarian diet

Plant-based vs. meat-based diets: Going vegan linked to better cardiovascular health in identical twin study

Researchers focused on 22 pairs of identical twins for 8 weeks, asking one twin to follow a healthy vegan diet and the other to follow a healthy omnivorous diet.

healthcare money economics dollar stethoscope acquire merger

Roche spends $2.7B to acquire biotech company with multiple obesity, diabetes drugs in development

Roche, one of the world’s largest pharmaceutical companies, will gain both oral and injectable assets as a result of this acquisition.

Surgeons Operating On Patient

‘We should halt this practice’: Common hormone treatment for donated hearts may be harmful

"This practice has been adopted by multiple organ-procurement organizations and is used on thousands of organ donors each year, without ever having been rigorously studied," one researcher said. 

semaglutide wegovy Novo Nordisk major adverse cardiovascular events

New formula could mean diabetes and weight loss drugs such as semaglutide are only needed every 4 months

GLP-1 agonists are often taken as daily or weekly injections. A new delivery system could help make it so those same drugs are only required three times per year. 

the words "FDA recall" on a board

FDA announces recall of infusion sets due to defect that puts diabetes patients at risk

The FDA considers this a Class I recall, which means using the impacted devices “may cause serious injuries or death.” One patient injury has been reported at this time. 

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.